Vericel to Present at Multiple Upcoming Investor Conferences

Rhea-AI Summary

Vericel (NASDAQ:VCEL) will present at multiple investor conferences in March 2026. The company confirmed presentations at the TD Cowen 46th Annual Healthcare Conference on March 4, 2026, and the Leerink Partners 2026 Global Healthcare Conference on March 10, 2026.

A webcast of the presentations will be available via the company's investor relations website.

CAMBRIDGE, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will present at the following investor conferences:

• TD Cowen 46^th Annual Healthcare Conference on Wednesday, March 4^th, 2026
• Leerink Partners 2026 Global Healthcare Conference on Tuesday, March 10^th, 2026

A webcast of the presentations will be available on the Investor Relations section of the Vericel Corporation website at: http://investors.vcel.com.

About Vericel Corporation
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. Vericel markets three products in the United States. MACI^® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. Vericel also holds an exclusive license for North American rights to NexoBrid® (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. For more information, please visit www.vcel.com.

Epicel^® and MACI^® and MACI Arthro® are registered trademarks of Vericel Corporation. NexoBrid^® is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. ©2026 Vericel Corporation. All rights reserved.

Investor Contact: 
Eric Burns
ir@vcel.com
+1 (734) 418-4411

FAQ

When will Vericel (VCEL) present at the TD Cowen 46th Annual Healthcare Conference?

Vericel will present on March 4, 2026 at the TD Cowen conference. According to the company, a webcast of the presentation will be available on Vericel's investor relations website for remote viewers.

On what date will Vericel (VCEL) present at the Leerink Partners 2026 Global Healthcare Conference?

Vericel will present on March 10, 2026 at the Leerink Partners conference. According to the company, the presentation will be webcast and accessible via the company's investor relations webpage.

How can investors watch Vericel's (VCEL) conference presentations if they cannot attend?

Investors can watch via a webcast on Vericel's investor relations website. According to the company, both conference presentations will be made available online for remote access.

Will Vericel (VCEL) provide slides or replay for the March 2026 conference presentations?

The company announced a webcast of the presentations, implying online access and possible replay. According to the company, the investor relations site will host the webcast and any related presentation materials if made available.

What topics will Vericel (VCEL) cover at the March 2026 investor conferences?

The company announced it will present at two healthcare conferences in March 2026 but did not list topics. According to the company, details and presentation materials will be posted on Vericel's investor relations website.

Where is the webcast of Vericel's (VCEL) March 2026 presentations hosted?

The webcast will be hosted on Vericel's investor relations website at investors.vcel.com. According to the company, attendees and remote viewers can access the presentations via that webpage.